candesartan cilexetil has been researched along with Cholestasis in 2 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Cholestasis: Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, H | 1 |
| Nakanishi, T | 1 |
| Tamai, I | 1 |
| Sturm, N | 1 |
| Hilleret, MN | 1 |
| Dreyfus, T | 1 |
| Barnoud, D | 1 |
| Leroy, V | 1 |
| Zarski, JP | 1 |
2 other studies available for candesartan cilexetil and Cholestasis
| Article | Year |
|---|---|
More relevant prediction for in vivo drug interaction of candesartan cilexetil on hepatic bile acid transporter BSEP using sandwich-cultured hepatocytes.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Benzimi | 2014 |
[Candesartan Cilexetil (Atacand) induced prolonged severe cholestasis improved by extracorporeal albumin dialysis].
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Component Removal; Cholestasis; E | 2005 |